UNSPSC 51281810: Valrubicin

This classification denotes an anthracycline antibiotic with the molecular formula C34H36F3NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2C6NUM6878, chemically known as pentanoic acid, 2-((2s,4s)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetylamino)-, alpha-l-lysohexopyranoxyl)oxy)-2-naphthacenyl)-2-oxoethyl ester but generally known as valrubicin, which bears US NIH Compound Identifier 41744.

UNSPSC 51281810 Valrubicin, a Commodity code, nominally designates a specific chemotherapy agent, but recent state and local solicitations tagged with this code show little alignment with that narrow pharmaceutical product scope. Instead, the opportunities posted under this code span a broad range of medical, pharmaceutical, and emergency response supply procurement — including naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, fire department medical and first aid supplies, and generic multi-source pharmaceuticals and over-the-counter products. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP). The work being solicited spans consumable medical supplies, emergency response equipment, pharmacy benefit program design and direct-to-manufacturer contracting, and manufacturer-direct pharmaceutical sourcing arrangements. Procurement vehicles include traditional sealed-bid invitations to bid (IFB), requests for information (RFI), and cooperative purchasing RFPs with multi-award structures.

Activity under this code appears concentrated in the Southeast and Upper Midwest, with recent solicitations from Florida, Texas, Minnesota, and Oregon. Representative recent opportunities include Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida; the Texas HHS Commission's RFI HHS0017013, posted April 3, 2026, gathering vendor capabilities for direct-to-manufacturer prescription programs; the City of Tampa's IFB 26-P-00145, posted March 25, 2026, with a response deadline of March 13, 2026, soliciting 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract amount of $700,000, designated as a sheltered market opportunity for certified small local business enterprises with a 5% bid discount; and MMCAP's RFP S1070000015802, posted January 20, 2026, with a proposal deadline of March 26, 2026, establishing multiple contracts for generic multi-source pharmaceuticals and OTC products distributed to state and local government facilities across participating jurisdictions. The code's recent activity reflects a mismatch between its nominal scope and the actual procurement landscape, suggesting that state and local buyers are using this classification to capture a wider category of pharmaceutical and medical supply sourcing than the code's title implies.